AMGEN Inc(AMGN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:59 PM ET (Korea 9/12 08:59)
Full metrics table
| Index | DJIA, NDX, S&P 500 | P/E | 23.43 | EPS (ttm) | 16.1 | Insider Own | 0.24% | Shs Outstand | 540.6M | Perf Week | -15.06% |
| Market Cap | 203.95B | Forward P/E | 15.45 | EPS next Y | 5.83% | Insider Trans | -0.87% | Shs Float | 539.3M | Perf Month | -9.36% |
| Enterprise Value | 247.26B | PEG | 2.74 | EPS next Q | 5.79 | Inst Own | 85.58% | Short Float | 2.41% | Perf Quarter | 6.55% |
| Income | 8.74B | P/S | 5.34 | EPS this Y | 5.66% | Inst Trans | - | Short Ratio | 4.76 | Perf Half Y | 2.57% |
| Sales | 38.20B | P/B | 17.45 | EPS next 5Y | 5.64% | ROA | 9.53% | Short Interest | 12.97M | Perf YTD | 15.25% |
| Book/sh | 21.62 | P/C | 14.58 | EPS past 3/5Y | 5.51% 2.93% | ROE | 91.47% | 52W High | -15.61% ($447.03) | Perf Year | 33.43% |
| Cash/sh | 25.88 | P/FCF | 20.04 | Sales past 3/5Y | 12.09% 7.79% | ROIC | 13.76% | 52W Low | 39.84% ($269.77) | Perf 3Y | 44.14% |
| Dividend Est. | $10.11 (2.68%) | EV/EBITDA | 14.22 | EPS Y/Y TTM | 31.69% | Gross Margin | 72.71% | Volatility(W/M) | 2.49% 2.08% | Perf 5Y | 76.49% |
| Dividend TTM | 9.94 | EV/Sales | 6.47 | Sales Y/Y TTM | 9.89% | Oper. Margin | 33.31% | ATR (14) | 11.5 | Perf 10Y | 126.5% |
| Dividend Ex-Date | 2026/8/21 | Quick Ratio | 1.13 | EPS Q/Q | 64.93% | Profit Margin | 22.89% | RSI (14) | 31.42 | Recom | 2.53 |
| Dividend Gr. 3/5Y | 7.05% 8.27% | Current Ratio | 1.37 | Sales Q/Q | 9.82% | SMA20 | -11.32% ($425.39) | Beta | 0.43 | Target Price | $395.75 |
| Payout | 66.92% | Debt/Eq | 4.9 | Earnings | 2026/8/4 | SMA50 | -5.48% ($399.11) | Rel Volume | 0.81 | Prev Close | $382.47 |
| Employees | 31500 | LT Debt/Eq | 4.44 | EPS/Sales Surpr. | 11.97% 6.66% | SMA200 | 4.97% ($359.38) | Avg Volume(3M) | 2.73M | Price | $377.24 |
| IPO | 1983/6/17 | Option/Short | Yes/Yes | Trades | 43531 | Volume | 2,200,943 | Change | -1.37% |
Company
AMGN is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 A global large-cap pharmaceutical and biotech company focused on biopharmaceuticals and biologics. Founded in California in 1980, it holds a portfolio of blockbuster drugs spanning therapeutic areas such as osteoporosis, immunology, cardiovascular disease, and oncology, and is a representative biotech firm that combines stable cash flow with continued investment in research and development.
Over the past 1 year, roughly in the middle
16% below its 1-year high.
AMGN makes money exceptionally well
33.31% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +5.7% this year.
Tap to view numbers
The price looks about right
Trading at 23.4 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Would have changed by +44.1% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 2.68% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 85.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
BBH 0.15%
TBXU 0.09%
IBB 0.08%
IBBQ 0.07%
THNR 0.06%It ranks #4 in the industry
Based on market cap of $204B.
AMGN $204B PER 23.4
LLY $1.1T PER 37.9
JNJ $640B PER 30.8
ABBV $454B PER 72.7
실적분석 · 8/4 Amgen ($AMGN) Q2 2026 Earnings Analysis — Adjusted EPS and Revenue Both Beat Estimates, Modest After-Hours Gain 투자 가이드 · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is AMGN?
AMGN belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is the market cap of AMGN?
The market cap of AMGN is approximately $203.9B, ranking 78 within its sector.
Does AMGN pay dividends?
AMGN has a dividend yield of approximately 2.68%, with an annual dividend of $10.11.
What is the P/E ratio of AMGN?
AMGN has a P/E ratio of approximately 23.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for AMGN?
AMGN has recorded a 52-week high of $447.03 and a low of $269.77.
